Cecilia Monge, M.D., M.P.H., FACP

Cecilia Monge, M.D., M.P.H., FACP
Assistant Research Physician

Team Member of:

Dr. Cecilia Monge specializes in first-in-human and early-phase clinical studies of gastrointestinal (GI) malignancies, including liver cancer, biliary tract cancer, colorectal cancer and pancreatic cancer.

Areas of Expertise

1) gastrointestinal (GI) malignancies, 2) hepatocellular carcinoma, 3) biliary tract cancer,
4) colorectal cancer, 5) pancreatic cancer

Contact Info

Cecilia Monge, M.D., M.P.H., FACP
Center for Cancer Research
National Cancer Institute
Building 10, Room 3B34
Bethesda, MD 20892
Ph: 240-858-3603
cecilia.mongebonilla@nih.gov

Dr. Cecilia Monge is involved in clinical research focusing on novel first-in-human and early-phase clinical trials within the realm of gastrointestinal (GI) tumors and immunology. She has served as chair and investigator of multiple early stage clinical protocols within the National Cancer Institute, National Institutes of Health.

NIH Scientific Focus Areas:
Clinical Research

Selected Key Publications

  1. Clara JA, Monge C, Yang Y, Takebe N.
    Nat Rev Clin Oncol. Epub ahead of print, 2019. [ Journal Article ]
  2. Role of HSP90 Inhibitors in the Treatment of Cancer.
    O’Sullivan Coyne G, Monge C, Chen AP.
    In: Heat Shock Protein 90 in Human Diseases and Disorders. (Asea AA, Kaur P, eds.). Vol. 19: Springer 125-143, 2019. [ Book Chapter ]
  3. Floudas CS, Brar G, Mabry-Hrones D, Duffy AG, Wood B, Levy E, Krishnasamy V, Fioravanti S, Bonilla Monge CM, Walker M, Morelli MP, Kleiner DE, Steinberg SM, Figg WD, Greten TF, Xie C
    Clin Colorectal Cancer. Epub ahead of print (Jul 2), 2019. [ Journal Article ]
  4. Cooper HA, Monge C, Panza JA
    Coron Artery Dis. 19(4): 231-5, 2008. [ Journal Article ]

Dr. Cecilia Monge joined the Thoracic and GI Malignancies Branch as Staff Oncology Physician in 2019 after finishing her oncology fellowship with an outstanding academic award at the National Institutes of Health (NIH).  She holds a Masters degree in public health from the Johns Hopkins University, Bloomberg School of Public Health and was selected to participate in the Global Clinical Scholars Research Training Program at Harvard Medical School. Dr. Monge completed her internal medicine training at Georgetown University after graduating from the Universidad de Costa Rica Medical School. 

Dr. Cecilia Monge is the recipient of multiple national and international academic and research awards in oncology and internal medicine.  She serves as a reviewer for various oncology  academic journals and is a member of the American Academy of Cardiology (ACC) Cardio-Oncology Guidelines Writing Committee and the American Society of Clinical Oncology (ASCO) Trainee Council.  Dr. Monge also serves on the NIH National Cancer Institute Institutional Scientific Review Board (IRB) for Clinical Studies and she is a fellow of the American College of Physicians.